Current Opinion in Pharmacology

Papers
(The TQCC of Current Opinion in Pharmacology is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-02-01 to 2024-02-01.)
ArticleCitations
Targeting CD73 to augment cancer immunotherapy73
Next-generation drug repurposing using human genetics and network biology55
The molecular link between oxidative stress, insulin resistance, and type 2 diabetes: A target for new therapies against cardiovascular diseases48
Gestational diabetes: Implications for fetal growth, intervention timing, and treatment options44
Adult hippocampal neurogenesis and antidepressants effects43
Prospects for COPD treatment43
Nanotechnology in pulmonary medicine42
Alleviating tumor hypoxia with perfluorocarbon-based oxygen carriers41
Adipose tissue depot differences in adipokines and effects on skeletal and cardiac muscle39
Endocannabinoid system and adult neurogenesis: a focused review39
Transforming targeted cancer therapy with PROTACs: A forward-looking perspective35
Dyslipidemia and diabetes mellitus: Role of lipoprotein species and interrelated pathways of lipid metabolism in diabetes mellitus35
Understanding the effects of air pollution on neurogenesis and gliogenesis in the growing and adult brain34
The regulatory roles of dietary fibers on host health via gut microbiota-derived short chain fatty acids34
Modulation of gut microbiota to overcome resistance to immune checkpoint blockade in cancer immunotherapy31
Targeting B cells for inflammatory bowel disease treatment: back to the future30
Neuroimmune and epigenetic mechanisms underlying persistent loss of hippocampal neurogenesis following adolescent intermittent ethanol exposure30
Bile acid-activated receptors and the regulation of macrophages function in metabolic disorders30
Recent discoveries in HIV-1 reverse transcriptase inhibitors29
Targeting the A2AR in cancer; early lessons from the clinic29
Gut microbiota and regulation of myokine-adipokine function29
Impact of gut microbiota on neurogenesis and neurological diseases during infancy28
Emerging mutations in the SARS-CoV-2 variants and their role in antibody escape to small molecule-based therapeutic resistance28
Myokines and adipokines in sarcopenia: understanding cross-talk between skeletal muscle and adipose tissue and the role of exercise27
Role of HSV-1 in Alzheimer's disease pathogenesis: A challenge for novel preventive/therapeutic strategies27
A review of emerging neuroprotective and neuroregenerative therapies in traumatic spinal cord injury27
Role of O-linked N-acetylglucosamine (O-GlcNAc) modification of proteins in diabetic cardiovascular complications27
Antihypertensive effect of soybean bioactive peptides: A review25
Exercise and browning of white adipose tissue – a translational perspective25
Astrocytes as cellular mediators of cue reactivity in addiction24
Exercise as a drug for glucose management and prevention in type 2 diabetes mellitus24
Targeting fibroblast-like synoviocytes in rheumatoid arthritis23
The role of the liver in the modulation of glucose and insulin in non alcoholic fatty liver disease and type 2 diabetes23
Glutamate receptors and metaplasticity in addiction23
Circadian control of human cardiovascular function22
Chronotherapy of cardiac and vascular disease: timing medications to circadian rhythms to optimize treatment effects and outcomes22
Treatments for COVID-19: Lessons from 2020 and new therapeutic options22
Treatment of early rheumatoid arthritis: Methotrexate and beyond22
Paeoniflorin is a promising natural monomer for neurodegenerative diseases via modulation of Ca2+ and ROS homeostasis21
Renal protection with glucagon-like peptide-1 receptor agonists21
Non-nucleoside reverse transcriptase inhibitors (NNRTIs): a brief overview of clinically approved drugs and combination regimens21
N-methyl-d-aspartate receptor function in neuronal and synaptic development and signaling21
Rejuvenating subventricular zone neurogenesis in the aging brain20
Drug-resistance in rheumatoid arthritis: the role of p53 gene mutations, ABC family transporters and personal factors20
NG2 cells and their neurogenic potential20
Rethinking the clinical management of volumetric muscle loss in patients with spinal cord injury: Synergy among nutritional supplementation, pharmacotherapy, and rehabilitation20
The role of faecal microbiota transplantation in the treatment of inflammatory bowel disease20
Monitoring vedolizumab and ustekinumab drug levels in patients with inflammatory bowel disease: hype or hope?20
Ependymal cells in the spinal cord as neuronal progenitors20
Metabolic adaptations after bariatric surgery: adipokines, myokines and hepatokines20
Current advances in the treatment of systemic sclerosis19
Alpha1-antitrypsin deficiency: New therapies on the horizon19
The pleiotropic roles of autophagy in Alzheimer's disease: From pathophysiology to therapy19
Disruption of energy utilization in diabetic cardiomyopathy; a mini review19
Modafinil and its structural analogs as atypical dopamine uptake inhibitors and potential medications for psychostimulant use disorder19
MicroRNAs as mediators of drug resistance mechanisms18
Adoptive cell therapy for solid tumors: Chimeric antigen receptor T cells and beyond18
Anti-inflammatory glucocorticoid action: genomic insights and emerging concepts18
Environmental enrichment-inspired pharmacological tools for the treatment of addiction18
Updated pharmacological effects of Lonicerae japonicae flos, with a focus on its potential efficacy on coronavirus disease–2019 (COVID-19)17
New drugs in the pipeline for the treatment of inflammatory bowel diseases: what is coming?17
Cost-effectiveness of therapeutic drug monitoring in inflammatory bowel disease17
Circadian influence on inflammatory response during cardiovascular disease17
Does probiotics work for bacterial vaginosis and vulvovaginal candidiasis17
TMEM16A (ANO1) as a therapeutic target in cystic fibrosis17
Applications of chemogenetics in non-human primates17
Kinase inhibitors in the treatment of obstructive pulmonary diseases16
Phosphodiesterase isoforms and cAMP compartments in the development of new therapies for obstructive pulmonary diseases16
Beyond antibodies: ankyrins and DARPins. From basic research to drug approval16
Role of the endocannabinoid system in the regulation of the skeletal muscle response to exercise16
Current state of CFTR modulators for treatment of Cystic Fibrosis16
Photopharmacological control of cell signaling with photoswitchable lipids16
Intersection of immunometabolism and immunosenescence during aging16
Testosterone therapy for prevention and reversal of type 2 diabetes in men with low testosterone16
Integrating the roles of liver X receptors in inflammation and infection: mechanisms and outcomes16
New insights into the regulatory roles of microRNAs in adult neurogenesis15
Current pharmacological intervention and development of targeting IVIG resistance in Kawasaki disease15
Probing function in 3D neuronal cultures: A survey of 3D multielectrode array advances14
Regulation of adipose tissue and skeletal muscle substrate metabolism by the stomach-derived hormone, ghrelin14
Histone deacetylases 1, 2 and 3 in nervous system development14
Mechanisms underlying N3-PUFA regulation of white adipose tissue endocrine function14
Non-alcoholic fatty liver disease: Current therapeutic options14
Prospects for severe asthma treatment14
Lynx1 prototoxins: critical accessory proteins of neuronal nicotinic acetylcholine receptors14
The hypodopaminergic state ten years after: transcranial magnetic stimulation as a tool to test the dopamine hypothesis of drug addiction14
The 2013–2016 Ebola virus disease outbreak in West Africa14
Effects of functional electrical stimulation on muscle health after spinal cord injury14
Immunogenicity, breakthrough infection, and underlying disease flare after SARS-CoV-2 vaccination among individuals with systemic autoimmune rheumatic diseases14
Nutrients and neurogenesis: the emerging role of autophagy and gut microbiota14
Lipid metabolism as a mechanism of immunomodulation in macrophages: the role of liver X receptors14
Lipid deposition and metaflammation in diabetic kidney disease13
Muscle multiorgan crosstalk with MG53 as a myokine for tissue repair and regeneration13
Role of intestinal glucose absorption in glucose tolerance13
The e-psychonaut drugs’ psychopharmacology13
RNAi therapeutics: an antiviral strategy for human infections13
Oxygenation and A2AR blockade to eliminate hypoxia/HIF-1α-adenosinergic immunosuppressive axis and improve cancer immunotherapy13
Microbiota-gut-brain axis: A novel potential target of ketogenic diet for epilepsy13
Optical control of Class A G protein-coupled receptors with photoswitchable ligands13
Untangling human neurogenesis to understand and counteract brain disorders12
Recent insights into astrocytes as therapeutic targets for demyelinating diseases12
Contribution of the bone marrow stromal cells in mediating drug resistance in hematopoietic tumors12
Design strategies for long-acting anti-HIV pharmaceuticals12
Therapeutics development for Ebola virus disease: A recent scenario12
Molecular routes to sarcopenia and biomarker development: per aspera ad astra12
Role of CD38/cADPR signaling in obstructive pulmonary diseases12
Genetic risk scores and personalization of care in fatty liver disease12
The changing landscape of the cystic fibrosis lung environment: From the perspective of Pseudomonas aeruginosa12
Promising therapeutic approaches in pulmonary arterial hypertension12
Pharmacological modulation of GABAA receptors11
Recent advances in the role of interleukin-6 in health and disease11
Current pharmacological treatment of hepatocellular carcinoma11
Elexacaftor–tezacaftor–ivacaftor: The new paradigm to treat people with cystic fibrosis with at least one p.Phe508del mutation11
Highland mate: Edible and functional foods in traditional medicine for the prevention and treatment of hypoxia-related symptoms11
Pharmacology of pannexin channels11
Evolving understanding of cardiovascular protection by SGLT2 inhibitors: focus on renal protection, myocardial effects, uric acid, and magnesium balance11
Quantitative assessment of volumetric muscle loss: Dual-energy X-ray absorptiometry and ultrasonography11
Targeting cellular senescence as a new approach to chronic obstructive pulmonary disease therapy11
Immune dysfunction after spinal cord injury – A review of autonomic and neuroendocrine mechanisms11
Targeting drug memory reconsolidation: a neural analysis11
Role of metformin and other metabolic drugs in the prevention and therapy of endocrine-related cancers11
0.028164148330688